D-Index & Metrics Best Publications

Alan C. Sartorelli

Yale University
United States

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name Citations Publications World Ranking National Ranking

Biology and Biochemistry D-index 78 Citations 21,436 513 World Ranking 2843 National Ranking 1505

Research.com Recognitions

Awards & Achievements

1990 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

What are the main themes of his work throughout his whole career to date

His Biochemistry study often links to related topics such as Cytotoxic T cell. His In vitro research extends to the thematically linked field of Cytotoxic T cell. In vitro and Cytotoxicity are commonly linked in his work. Alan C. Sartorelli integrates many fields in his works, including Cytotoxicity and DNA. He integrates DNA and DNA damage in his studies. His research is interdisciplinary, bridging the disciplines of Biochemistry and DNA damage. His Semicarbazone research extends to Stereochemistry, which is thematically connected. His Semicarbazone study frequently involves adjacent topics like Stereochemistry. In his works, Alan C. Sartorelli undertakes multidisciplinary study on Gene and Red blood cell.

Alan C. Sartorelli most often published in these fields:

Biochemistry (66.67%)
Stereochemistry (33.33%)
Gene (33.33%)

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Classification of Antineoplastic Agents by their Selective Toxicities toward Oxygenated and Hypoxic Tumor Cells

Beverly A. Teicher;John S. Lazo;Alan C. Sartorelli.
Cancer Research (1981)

712 Citations

The Leukotriene C4 Transporter MRP1 Regulates CCL19 (MIP-3β, ELC)–Dependent Mobilization of Dendritic Cells to Lymph Nodes

Davide F Robbiani;Rick A Finch;Dirk Jäger;William A Muller.
Cell (2000)

574 Citations

Triapine (3-aminopyridine-2-carboxaldehyde- thiosemicarbazone): A potent inhibitor of ribonucleotide reductase activity with broad spectrum antitumor activity

Rick Avery Finch;Mao Chin Liu;Susan P. Grill;William C. Rose.
Biochemical Pharmacology (2000)

426 Citations

The hypoxic tumor cell: a target for selective cancer chemotherapy.

Katherine A. Kennedy;Beverly A. Teicher;Sara Rockwell;Alan C. Sartorelli.
Biochemical Pharmacology (1980)

415 Citations

Differentiation of immortal cells inhibits telomerase activity.

Harsh W. Sharma;John A. Sokoloski;Jose R. Perez;Jean Yves Maltese.
Proceedings of the National Academy of Sciences of the United States of America (1995)

389 Citations

Evidence that the multidrug resistance protein (MRP) functions as a co-transporter of glutathione and natural product toxins.

Germana Rappa;Aurelio Lorico;Richard A. Flavell;Alan C. Sartorelli.
Cancer Research (1997)

364 Citations

Therapeutic attack of hypoxic cells of solid tumors: presidential address

Alan C. Sartorelli.
Cancer Research (1988)

353 Citations

Preferential Activation of Mitomycin C to Cytotoxic Metabolites by Hypoxic Tumor Cells

Katherine A. Kennedy;Sara Rockwell;Alan C. Sartorelli.
Cancer Research (1980)

308 Citations

Disruption of the murine MRP (multidrug resistance protein) gene leads to increased sensitivity to etoposide (VP-16) and increased levels of glutathione.

Aurelio Lorico;Germana Rappa;Rick A. Finch;Di Yang.
Cancer Research (1997)

301 Citations

Randomized clinical trial of mitomycin C as an adjunct to radiotherapy in head and neck cancer.

Joseph B. Weissberg;Yung H. Son;Rose J. Papac;Clarence Sasaki.
International Journal of Radiation Oncology Biology Physics (1989)

287 Citations

If you think any of the details on this page are incorrect, let us know.